Contact : Tu To (213) 229-5436

Travere Therapeutics focuses on rare kidney and metabolic diseases, with strong revenue growth from recently approved Filspari and a narrowing loss in Q1 2024. Analysts generally remain bullish, with multiple Buy ratings and price targets ranging from $22 to $45 a share on the stock that current trades around $17.00 a share. The company did suffer a bit of setback last week as the FDA moved back the anticipated decision date on a recently submitted sNDA.

Target Corp (NYSE:TGT) is expected to report fiscal first-quarter earnings on Wednesday, with Bank of America forecasting results ahead of Wall Street estimates despite ongoing pressure from soft discretionary spending and rising costs. Analysts project adjusted earnings per share of $1.78 and a 1% decline in comparable sales for the quarter.

Tesla's chief financial officer, Vaibhav Taneja, took home a $139 million pay package last year. It was tied to stock options and equity awards, according to a regulatory filing.

The Dockers brand, long synonymous with Levi Strauss is getting a new owner as Authentic Brands has agreed to purchase the casual clothing line for a deal with over $300M

Tesla CEO Elon Musk joins 'Power Lunch' to discuss the company's autonomous vehicle ambitions, the logistics behind them, and much more.

atai Life Sciences (NASDAQ:ATAI, ETR:9VC) could see its stock more than double following the release of key trial data later in 2025, according to Jefferies analysts, following another batch of positive clinical trial results from Beckley Psytech's BPL-003 program targeting treatment-resistant depression (TRD). Beckley Psytech's Phase 2a study of BPL-003, an intranasal form of 5-MeO-DMT, showed that a single dose of the therapy along with selective serotonin reuptake inhibitor (SSRI) therapies, produced rapid, robust, and sustained antidepressant effects.

The U.K.'s Competition Appeal Tribunal announced its judgment Tuesday (May 20) in a long-running class action lawsuit that was brought against Mastercard over its swipe fees. The judgment determines the distribution of the settlement of 200 million pounds that was announced in February, the Competition Appeal Tribunal said in a summary of the judgment.

As U.S. growth outlooks face increasing challenges this year, diversifying beyond growth-heavy, large-cap benchmarks could prove beneficial. SMIDcap stocks offer a number of opportunities for investors.

On this week's episode of ETF Prime, Kirsten Chang, senior industry analyst at VettaFi, joins host Nate Geraci to provide a comprehensive overview of current trends and investor sentiment in the fixed income ETF space. Later, Tidal's Mike Venuto highlights the latest developments in ETF innovation.

I reiterate my Strong Buy rating on Broadcom Inc., with a fair value estimate of $247 per share, driven by robust data center and AI demand. Hyperscalers' sustained and rising CAPEX signals healthy near-term growth for Broadcom's semiconductor solutions, especially in custom silicon for AI and cloud. Broadcom's new co-packaged optics and strong AI revenue guidance position it as a leader in addressing bandwidth and latency challenges in AI infrastructure.

Elon Musk, Tesla CEO, joins 'Power Lunch' to discuss the company's autonomous ambitions, and the chief executive's thoughts on his politics involvements.

Elbit Systems Ltd. (NASDAQ:ESLT ) Q1 2025 Earnings Conference Call May 20, 2025 9:00 AM ET Company Participants Daniella Finn - Vice President, Investor Relationship Kobi Kagan - Chief Financial Officer Butzi Machlis - President and Chief Executive Officer Conference Call Participants Conor Walters - Jefferies Omri Efroni - Oppenheimer Operator Ladies and gentlemen, thank you for standing by.

The tech giant announced new AI features in Search at its I/O developer conference as it tries to fend off upstart competition in the search-engine business

Here, we have picked three AI stocks, MSFT, CTSH and LRCX, which are well poised to benefit from AI's growing usage and ability to solve complex problems.

NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your Compass Group Diversified Holdings, LLC (NYSE:CODI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/compass-diversified-lawsuit-submission-form?prid=149431&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your Krispy Kreme, Inc. (NASDAQ:DNUT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/krispy-kreme-inc-lawsuit-submission-form?prid=149430&wire=1&utm_campaign=16 or contact Joseph E. Levi, Esq.

RADNOR, PA / ACCESS Newswire / May 20, 2025 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against SoundHound AI, Inc. ("SoundHound") (NASDAQ:SOUN) on behalf of those who purchased or otherwise acquired SoundHound securities between May 10, 2024, and March 3, 2025, inclusive (the "Class Period"). The lead plaintiff deadline is May 27, 2025.

NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your Everus Construction Group, Inc. (NYSE:ECG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/everus-construction-group-inc-lawsuit-submission-form?prid=149432&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq.

OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has downgraded the Long-Term Issuer Credit Ratings (Long-Term ICR) to “a” (Excellent) from “a+” (Excellent) and affirmed the Financial Strength Rating (FSR) of A (Excellent) of the members of Nodak Insurance Group (Nodak). The outlook of the Long-Term ICRs has been revised to stable from negative, while the outlook of the FSR is stable. Concurrently, AM Best has downgraded the Long-Term ICR to “bbb” (Good) from “bbb+” (Good) of NI Holdings, Inc. (Fargo, N.